mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.04 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.04 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |